Responses
Clinical and epidemiological research
Extended report
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
Compose a Response to This Article
Other responses
No responses have been published for this article.